The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)Shenzhen Energy Investment established a new energy development company, and the enterprise search APP showed that recently, Shenneng (Zhuolu) New Energy Development Co., Ltd. was established, with Li Xuedong as the legal representative and a registered capital of 2 million yuan. Its business scope includes: solar power generation technical services; Technical services for wind power generation; Research and development of wind farm related systems; Energy storage technology services, etc. Enterprise survey shows that the company is indirectly wholly-owned by Shenzhen Energy.China encourages qualified medical and nursing institutions to be integrated into the unified management of the compact medical association. It was learned from the National Health and Health Commission that the five departments jointly issued a document proposing that the medical and health administrative departments at all levels should integrate the medical and health services of the old-age care institutions into the quality and safety management system, and encourage qualified medical and nursing institutions to be integrated into the unified management of the compact medical association. The Guiding Opinions on Promoting the High-quality Development of the Combination of Medical Care and Health Care, jointly issued by the National Health and Wellness Commission, the Ministry of Civil Affairs, the State Medical Insurance Bureau and other departments, is deployed from four aspects: quality management, service quality and efficiency, team building and service safety. It is necessary to continuously enhance the sense of healthy old-age care for the elderly. The data shows that by the end of 2023, the number of elderly people aged 60 and over in China reached 297 million, accounting for 21.1% of the total population. Promoting the combination of medical care and nursing care is an important measure to optimize the health of the elderly and the supply of old-age services. (Xinhua News Agency)
ByteDance and Peking University set up the Joint Lab of Bean Bag Large Model System Software. On the evening of December 12th, the signing ceremony of Peking University-ByteDance Joint Lab of Bean Bag Large Model System Software and the academic seminar of "Intelligent Software Technology and Ecology for Large Model" were held in Yingjie Exchange Center, Peking University. Experts attending the meeting agreed that it is of great significance to promote the deep integration of Industry-University-Research to promote the breakthrough of core technologies of artificial intelligence. The establishment of this joint laboratory is an important milestone in collaborative innovation between schools and enterprises, and will jointly promote the technological innovation and application development of large-scale model system software based on the advantages of both parties. (Sina Technology)China encourages qualified medical and nursing institutions to be integrated into the unified management of the compact medical association. It was learned from the National Health and Health Commission that the five departments jointly issued a document proposing that the medical and health administrative departments at all levels should integrate the medical and health services of the old-age care institutions into the quality and safety management system, and encourage qualified medical and nursing institutions to be integrated into the unified management of the compact medical association. The Guiding Opinions on Promoting the High-quality Development of the Combination of Medical Care and Health Care, jointly issued by the National Health and Wellness Commission, the Ministry of Civil Affairs, the State Medical Insurance Bureau and other departments, is deployed from four aspects: quality management, service quality and efficiency, team building and service safety. It is necessary to continuously enhance the sense of healthy old-age care for the elderly. The data shows that by the end of 2023, the number of elderly people aged 60 and over in China reached 297 million, accounting for 21.1% of the total population. Promoting the combination of medical care and nursing care is an important measure to optimize the health of the elderly and the supply of old-age services. (Xinhua News Agency)Domestic futures opened mixed at night, with Shanghai copper down 0.56%, Shanghai zinc down 0.39%, Shanghai nickel up 1.75%, iron ore up 0.06%, coking coal up 0.42% and crude oil up 1.15%.
Western Securities and others set up a parent fund management partnership with a capital contribution of 2 billion yuan. According to Tianyancha APP, recently, Xiaogan Xizheng Gaochuang Industrial Investment Parent Fund Management Partnership (Limited Partnership) was established with a capital contribution of 2 billion yuan. Its business scope includes: private equity investment fund management, venture capital fund management services, etc. Tianyancha's equity penetration shows that the enterprise is jointly held by Western Advantage Capital Investment Co., Ltd., a wholly-owned subsidiary of Western Securities, and Xiaogan Gaochuang Investment Co., Ltd.Domestic futures opened mixed at night, with Shanghai copper down 0.56%, Shanghai zinc down 0.39%, Shanghai nickel up 1.75%, iron ore up 0.06%, coking coal up 0.42% and crude oil up 1.15%.Deutsche Bank appointed MARCUS CHROMIK as the new CRO.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14